Klingenstein Fields & CO LP Laboratory Corp Of America Holdings Transaction History

Klingenstein Fields & CO LP

$2.48 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$209.01 - $232.56 $29,679 - $33,023	-142 Reduced 4.44%	3,057 $667,000
Q4 2023 Feb 01, 2024	SELL	$197.69 - $227.29 $14,826 - $17,046	-75 Reduced 2.29%	3,199 $727,000
Q2 2023 Aug 01, 2023	SELL	$211.93 - $241.33 $4,238 - $4,826	-20 Reduced 0.61%	3,274 $790,000
Q3 2022 Oct 28, 2022	BUY	$204.81 - $262.19 $60,214 - $77,083	294 Added 9.8%	3,294 $675,000
Q2 2022 Aug 01, 2022	SELL	$213.86 - $277.87 $163,175 - $212,014	-763 Reduced 20.28%	3,000 $703,000
Q1 2022 Apr 27, 2022	SELL	$259.82 - $298.18 $569,265 - $653,312	-2,191 Reduced 36.8%	3,763 $992,000
Q4 2021 Jan 31, 2022	SELL	$271.6 - $314.21 $1.47 Million - $1.7 Million	-5,410 Reduced 47.61%	5,954 $1.87 Million
Q3 2021 Oct 26, 2021	SELL	$274.82 - $308.34 $40.6 Million - $45.5 Million	-147,650 Reduced 92.85%	11,364 $3.2 Million
Q2 2021 Jul 26, 2021	SELL	$251.87 - $278.14 $48,862 - $53,959	-194 Reduced 0.12%	159,014 $43.9 Million
Q1 2021 Apr 29, 2021	SELL	$204.88 - $255.03 $722,611 - $899,490	-3,527 Reduced 2.17%	159,208 $40.6 Million
Q4 2020 Feb 02, 2021	SELL	$186.91 - $214.42 $319,242 - $366,229	-1,708 Reduced 1.04%	162,735 $33.1 Million
Q3 2020 Oct 30, 2020	SELL	$167.03 - $201.3 $87,523 - $105,481	-524 Reduced 0.32%	164,443 $31 Million
Q2 2020 Aug 03, 2020	BUY	$113.31 - $182.44 $136,425 - $219,657	1,204 Added 0.74%	164,967 $27.4 Million
Q1 2020 May 07, 2020	SELL	$104.32 - $195.28 $513,463 - $961,168	-4,922 Reduced 2.92%	163,763 $20.7 Million
Q4 2019 Feb 04, 2020	SELL	$163.48 - $173.61 $395,948 - $420,483	-2,422 Reduced 1.42%	168,685 $28.5 Million
Q3 2019 Nov 01, 2019	BUY	$159.77 - $178.1 $1.58 Million - $1.76 Million	9,904 Added 6.14%	171,107 $28.7 Million
Q2 2019 Aug 12, 2019	BUY	$144.16 - $172.9 $291,491 - $349,603	2,022 Added 1.27%	161,203 $27.9 Million
Q1 2019 Apr 29, 2019	SELL	$123.7 - $156.3 $6.39 Million - $8.07 Million	-51,643 Reduced 24.5%	159,181 $24.4 Million
Q4 2018 Jan 22, 2019	SELL	$120.82 - $174.09 $216,146 - $311,447	-1,789 Reduced 0.84%	210,824 $26.6 Million
Q3 2018 Nov 01, 2018	SELL	$167.67 - $188.27 $350,933 - $394,049	-2,093 Reduced 0.97%	212,613 $36.9 Million
Q2 2018 Jul 26, 2018	BUY	$160.33 - $189.41 $165,139 - $195,092	1,030 Added 0.48%	214,706 $38.5 Million
Q1 2018 May 01, 2018	BUY	$161.53 - $178.11 $67,196 - $74,093	416 Added 0.2%	213,676 $34.6 Million
Q4 2017 Jan 30, 2018	SELL	$147.99 - $163.95 $50,908 - $56,398	-344 Reduced 0.16%	213,260 $34 Million
Q3 2017 Nov 01, 2017	BUY	$149.47 - $160.56 $31.9 Million - $34.3 Million	213,604	213,604 $32.2 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account